SVG

Ann Theodore Sarcoidosis Breakthrough Initiative Grant Program
Overview
The Ann Theodore Foundation partnered with the Science Philanthropy Accelerator for Research and Collaboration (SPARC) in 2020 to better understand the sarcoidosis landscape with the goal of developing philanthropic strategies that could be used to overcome barriers to scientific progress and improve clinical outcomes. The programbrings together all funded researchers for annual meetings, promotes the sharing of research and the development of collaborations across institutions that would otherwise go untapped.
Funded Research
Stats Items
$
0
M
in funding awarded
0
scientific research grants supported
0
interdisciplinary collaborations seeded
RFP: Ann Theodore Foundation Breakthrough Sarcoidosis Initiative
The Ann Theodore Foundation (ATF) is launching a new funding cycle for the Breakthrough Sarcoidosis Initiative in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC).

Sarcoidosis Scientific Advisory Board
Image

Catherine Bonham
Ann Theodore Foundation Breakthrough Sarcoidosis Initiative Scientific Advisory Board Member
Image

Erica Herzog
Ann Theodore Foundation Breakthrough Sarcoidosis Initiative Scientific Advisory Board Member
Image

Ogugua Obi
Ann Theodore Foundation Breakthrough Sarcoidosis Initiative Scientific Advisory Board Member
Ann Theodore Sarcoidosis Breakthrough Initiative Grant Program
Related Articles
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population...Read ReportSarcoidosis: A Giving Smarter Guide
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...Read ReportType 1 Diabetes Autoantibody Screening: A Roadmap for Pediatric Policy Implementation
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas. The disease affects people of all ages and causes numerous negative...Read Report